Wednesday, March 29, 2023


Biotechnology News Magazine


Futura Provides FDA Regulatory and Commercial Update for MED3000

James Barder, Chief Executive of Futura Medical commented: "Subject to receipt of the final meeting minutes we are pleased that the requirements to enable an OTC application for MED3000 have been clarified with the FDA.

Kintor Pharmaceutical Receives Emergency Use Authorization for Proxalutamide for the Treatment of COVID-19 in Paraguay

Dr. Youzhi Tong, the founder, Chairman, and CEO of Kintor Pharmaceutical, commented, "We are delighted to see that proxalutamide is saving lives in Paraguay following the EUA from the MSPBS. We are actively exploring additional EUAs of proxalutamide in other countries and regions to help COVID-19 patients around the world."

Vivera Pharmaceuticals Congratulates Clinical Research Partner, Parexel International, on its $8.5 Bil Acquisition

The company is proud to be working with Parexel, and supports the value Parexel continues to provide to the health care industry and patients beyond its well-deserved valuation.

Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax®-Enabled Pandemic Influenza Vaccine

Enesi Pharma announced that it has successfully developed an ImplaVax®-enabled, solid-dose recombinant H7N9 pandemic influenza vaccine and delivered proof-of-concept results in validated preclinical models.

ECI Pharmaceuticals LLC Enters into Exclusive U.S. Distribution Agreement for Ibuprofen Prescription Strength Tablets and Folic Acid Prescription Strength Tablets

According to IQVIA data for the 12 months ended December 2020, total U.S. generic sales of Ibuprofen tablets 400 mg, 600 mg, 800 mg was approximately $110 million.

AIkido Pharma Notes Advancement in Radiopharmaceutical Research

Alkido Pharma notes the report provides strong indications for analogous success in similar technology the Company is helping to develop.